Abstract

Invasive fungal infections are important causes of mortality and morbidity in immunodeficiencies, hematological malignancies, and transplant recipients. There is scarce information in the literature about the diagnosis, treatment methods, and management. Herein, a unique involvement site of invasive fungal infection caused by Aspergillus flavus in the nadir of the induction chemotherapy of a 13-year-old boy with the diagnosis of acute lymphoblastic leukemia is presented. Despite prolonged intravenous antifungal therapy, the patient exhibited an inadequate response. As a result, intra-articular antifungal treatment was implemented alongside curettage and joint space irrigation. These additional interventions led to significantly improved clinical outcomes. Since fungal osteomyelitis can be an important cause of mortality and morbidity in immunosuppressed patients, prompt diagnosis and multidisciplinary treatment are crucial.

Keywords: Fungal osteomyelitis, immunocompromised patients, aspergillosis, amphotericin B-resistant, management of invasive aspergillosis

Copyright and license

Copyright © 2024 The author(s). This is an open-access article published by Aydın Pediatric Society under the terms of the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite

1.
Akyol Ş, Erdoğmuş NA, Atalay MA, Karaman ZF, Özcan A, Kafadar İ, et al. Repetitive intra-articular therapy in fungal arthritis: Adjunct to systemic therapy in a patient with pediatric acute lymphoblastic leukemia. Trends in Pediatrics. 2024;5(3):101-104. https://doi.org/10.59213/TP.2024.173

References

  1. Patterson TF, Thompson GR, Denning DW, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63:e1-60. https://doi.org/10.1093/cid/ciw326
  2. Koutserimpas C, Chamakioti I, Raptis K, Alpantaki K, Vrioni G, Samonis G. Osseous Infections Caused by Aspergillus Species. Diagnostics (Basel). 2022;12:201. https://doi.org/10.3390/diagnostics12010201
  3. Cadena J, Thompson GR, Patterson TF. Aspergillosis: Epidemiology, Diagnosis, and Treatment. Infect Dis Clin North Am. 2021;35:415-34. https://doi.org/10.1016/j.idc.2021.03.008
  4. Sav H, Atalay MA, Koc AN, Unal E, Demir G, Zararsiz G. Utility of the Aspergillus galactomannan antigen testing for neutropenic paediatric patients. Infez Med. 2017;25:38-44.
  5. Koehler P, Tacke D, Cornely OA. Aspergillosis of bones and joints - a review from 2002 until today. Mycoses. 2014;57:323-35. https://doi.org/10.1111/myc.12165
  6. Anwer U, Yablon CM. Imaging of Osteomyelitis of the Extremities. Semin Roentgenol. 2017;52:49-54. https://doi.org/10.1053/j.ro.2016.05.011
  7. Reischies F, Hoenigl M. The role of surgical debridement in different clinical manifestations of invasive aspergillosis. Mycoses. 2014;57(Suppl. 2):1-14. https://doi.org/10.1111/myc.12224
  8. Papachristou SG, Iosifidis E, Sipsas NV, Gamaletsou MN, Walsh TJ, Roilides E. Management of osteoarticular fungal infections in the setting of immunodeficiency. Expert Rev Anti Infect Ther. 2020;18:461-74. https://doi.org/10.1080/14787210.2020.1748499
  9. Kawashima N, Yoshida N, Matsushita N, Ito M, Matsumoto K, Kato K. Intra-articular injection of voriconazole for Fusarium solani arthritis after bone marrow transplantation. J Infect. 2012;65:366-7. https://doi.org/10.1016/j.jinf.2012.06.001